CR10018A - - Google Patents

Info

Publication number
CR10018A
CR10018A CR10018A CR10018A CR10018A CR 10018 A CR10018 A CR 10018A CR 10018 A CR10018 A CR 10018A CR 10018 A CR10018 A CR 10018A CR 10018 A CR10018 A CR 10018A
Authority
CR
Costa Rica
Application number
CR10018A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CR10018A publication Critical patent/CR10018A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CR10018A 2005-12-01 2008-05-26 CR10018A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20050116567 2005-12-01

Publications (1)

Publication Number Publication Date
CR10018A true CR10018A (es) 2008-09-02

Family

ID=38092428

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10018A CR10018A (es) 2005-12-01 2008-05-26

Country Status (15)

Country Link
US (1) US7776873B2 (es)
EP (1) EP1954279A4 (es)
JP (1) JP5207974B2 (es)
KR (1) KR100805660B1 (es)
CN (2) CN101316594B (es)
AU (1) AU2006321471B2 (es)
BR (1) BRPI0619081A2 (es)
CA (1) CA2631068C (es)
CR (1) CR10018A (es)
EC (1) ECSP088545A (es)
HK (1) HK1123507A1 (es)
IL (1) IL191680A0 (es)
MY (1) MY145406A (es)
WO (1) WO2007064128A1 (es)
ZA (1) ZA200805747B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007339080B2 (en) * 2006-12-22 2012-09-27 Yuhan Corporation Revaprazan-containing solid dispersion and process for the preparation thereof
JP5802898B2 (ja) 2009-07-09 2015-11-04 ラクオリア創薬株式会社 消化管運動異常が関与する疾患を治療するためのアシッドポンプ拮抗剤
KR101730865B1 (ko) 2011-02-11 2017-04-27 주식회사유한양행 레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법
KR101739818B1 (ko) * 2011-05-20 2017-05-26 주식회사유한양행 레바프라잔 또는 그의 염을 함유하는 현탁액 형태의 경구투여용 약학 조성물
BR112018001859B1 (pt) 2015-07-30 2023-05-02 Takeda Pharmaceutical Company Limited Comprimido, e, método para produzir um comprimido
CN105998688A (zh) * 2016-06-22 2016-10-12 郑亮 一种胃粘膜损伤的抑制方法
KR20180107341A (ko) * 2017-03-16 2018-10-02 차의과학대학교 산학협력단 칼륨 경쟁적 위산분비억제제를 유효성분을 함유하는 장 누수 증후군 치료 및 예방용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN171746B (es) * 1989-11-02 1992-12-26 Mcneil Ppc Inc
DE69530989T2 (de) 1994-08-13 2004-05-19 Yuhan Corp. Neue pyrimidinderivate und verfahren zu ihrer herstellung
JP3160297B2 (ja) * 1996-05-04 2001-04-25 ユーハン・コーポレイション ピリミジン誘導体の製造方法
CN1088706C (zh) * 1996-10-25 2002-08-07 卫福有限公司 新型杂环酰胺化合物及其医药用途
HU226752B1 (en) 1996-10-29 2009-09-28 Yuhan Corp Process for preparation of pyrimidine derivatives
GB0110338D0 (en) * 2001-04-27 2001-06-20 Sb Pharmco Inc Novel processes
US8206741B2 (en) * 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs

Also Published As

Publication number Publication date
JP2009517462A (ja) 2009-04-30
AU2006321471A1 (en) 2007-06-07
HK1123507A1 (en) 2009-06-19
IL191680A0 (en) 2009-08-03
EP1954279A4 (en) 2009-06-03
KR20070057663A (ko) 2007-06-07
CA2631068C (en) 2011-01-11
CN102309490A (zh) 2012-01-11
CA2631068A1 (en) 2007-06-07
US7776873B2 (en) 2010-08-17
ZA200805747B (en) 2009-11-25
ECSP088545A (es) 2008-08-29
CN101316594B (zh) 2012-07-25
EP1954279A1 (en) 2008-08-13
MY145406A (en) 2012-02-15
BRPI0619081A2 (pt) 2011-09-20
KR100805660B1 (ko) 2008-02-21
WO2007064128A1 (en) 2007-06-07
AU2006321471B2 (en) 2010-07-29
JP5207974B2 (ja) 2013-06-12
US20070129391A1 (en) 2007-06-07
CN101316594A (zh) 2008-12-03

Similar Documents

Publication Publication Date Title
IN2006DE02733A (es)
BRPI0608519A2 (es)
BRPI0604219A (es)
JP2007013081A5 (es)
JP2005289047A5 (es)
BRPI0618215B8 (es)
JP2007009386A5 (es)
BY2237U (es)
JP2006329317A5 (es)
CN105122969C (es)
CN300725998S (zh) 鞋帮
CN300725994S (zh) 鞋底
CN300726016S (zh) 鞋帮
CN300726697S (zh) 调料瓶套装(b)
CN300726698S (zh) 调料瓶套装(e)
CN300726015S (zh) 鞋底
CN300725999S (zh) 鞋底
CN300726007S (zh) 鞋底
CN300726006S (zh) 鞋底
CN300726699S (zh) 调料瓶套装(d)
CN300728901S (zh) 吧台（1）
CN300729693S (zh) 表盘
CN300726005S (zh) 鞋帮
CN300726004S (zh) 鞋帮
CN300759109S (zh) 验电器(一字形)

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)